Mississippi Administrative Code › Title 15 - Mississippi Department of Health › Part 2 - Epidemiology › Subpart 11 - Office of Communicable Diseases › Chapter 1 - MISSISSIPPI STATE DEPARTMENT OF HEALTH RULES AND REGULATIONS GOVERNING REPORTABLE DISEASES AND CONDITIONS › Subchapter 17 - SPECIFIC DISEASE CONTROL MEASURES › Rule 15-2-11-1.17.17 - Tuberculosis

Current through June 25, 2024
1. Class 1A case report required.
2. Human Infections: The local health officer
					 shall determine and prescribe for individual cases and contacts the isolation,
					 quarantine restrictions and/or treatment necessary for their protection and
					 that of other people. Should any patient fail to observe the isolation methods
					 prescribed by the local health officer, said health officer shall quarantine
					 the patient in writing and prescribe therein the procedures to be carried out
					 by said patient. Should the patient break his/her quarantine restrictions, the
					 local health officer may apply by letter outlining the circumstances to the
					 Executive Secretary of the Mississippi State Board of Health and request
					 approval of proceedings to commit the patient to a hospital. Upon approval by
					 the Executive Secretary of the Mississippi State Board of Health, the local
					 health officer may initiate proceedings as provided by law for the forcible
					 commitment of the patient. (Sections
					 41-33-5,
					 41-33-7,
					 Mississippi Code of 1972 as amended.)
3. Control in Animals: Bovine tuberculosis
					 may be transmitted to man by infected cattle through close contact or the
					 consumption of raw milk. Milk shall be from dairy herds that comply with
					 tuberculosis requirements set forth in the current Mississippi State Board of
					 Health Regulations, and the Mississippi State Department of Health Regulations
					 Governing the Production and Sale of Milk and Milk Products.
4. Tuberculosis Management in Correctional
					 Institution: The following regulations govern all Mississippi state
					 correctional facilities, city and county facilities housing state prisoners,
					 and privately operated correctional facilities in the state.
a. "Correctional Institutions" and/or
					 "correctional facility" shall be construed to mean any of the state-operated
					 penitentiaries, privately operated correctional facilities, community work
					 centers, community pre-release centers, restitution centers, county or regional
					 correctional facilities, and/or administrative offices as is applicable to each
					 respective policy.
b. All inmates
					 shall be medically screened for communicable diseases (including Mycobacterium
					 tuberculosis [TB], syphilis, and Human Immunodeficiency Virus [HIV]) to prevent
					 the spread of these diseases within the correctional institutions and to the
					 public. Employees (i.e. full and part-time employees, contract staff and
					 volunteers) shall be screened for tuberculosis infection and disease.
c. The correctional institution shall
					 establish schedules, protocols, and responsibilities for the testing of inmates
					 and employees to ensure compliance with all relevant Mississippi State
					 Department of Health (MSDH) guidelines. The correctional institution shall
					 appoint a liaison to ensure that all necessary screening is provided to each
					 inmate and employee under its jurisdiction regardless of the individual's
					 physical location.
d. The director
					 of the correctional institution, in consultation with the correctional
					 institution's medical director, shall issue procedures to ensure that inmates,
					 prior to being transferred into the correctional institution from another
					 correctional institution, a non-state facility, or out-of-state jurisdiction
					 have been properly tested/screened for communicable disease within the previous
					 thirty (30) days. If such testing and screening has not been accomplished, the
					 director shall ensure that these procedures are completed prior to the transfer
					 or upon the receipt of the inmate.
e. Screening shall include a Rapid Plasma
					 Reagin (RPR) for syphilis, HIV serology, and TB testing, including, TB signs
					 and symptoms assessment, exposure history, two-step Mantoux tuberculin skin
					 test or blood assay for mycobacterium tuberculosis (BAMT) and chest x-ray if
					 indicated. All HIV-Positive inmates and employees shall have an x-ray as part
					 of the medical screening. No inmate shall be placed in the general population
					 until the medical assessment is completed. Any symptomatic inmate shall remain
					 in respiratory isolation until TB test results are known and active
					 tuberculosis disease has been ruled out. Documentation of these screening tests
					 shall be maintained for all inmates in a correctional institution. Test results
					 shall be reported to the MSDH.
f.
					 Screening, latent therapy, active treatment and treatment follow-up of inmates
					 and employees for tuberculosis shall follow the policies and procedures
					 included in the latest revision of the Tuberculosis Manual of the MSDH. All
					 latent and active TB treatment of the inmates shall be directly observed by a
					 health care provider.
g. The
					 correctional institution's medical director, in order to contain communicable
					 disease and/or enforce screening schedules, with the approval of the
					 correctional institutional superintendent and/or classification director shall
					 have the authority to:
i. Place inmates in
					 quarantine
ii. Suspend
					 employees
iii. Move inmates between
					 approved housing locations or to approved medical facilities
iv. Issue procedures for the care and
					 treatment of inmates and employees with communicable diseases
h. Each correctional institution
					 or correctional facility shall provide a complete, legible and accurate
					 Tuberculin Testing Summary (MSDH Form 181) summarizing the correctional
					 facility's tuberculin testing activity and containing a roster of all inmates
					 and employees that were first identified as having a significant Mantoux
					 tuberculin skin test reaction* or positive BAMT within the reporting period.
					 This roster shall include comments and conclusions concerning the individual
					 follow-up of each person listed. The Tuberculin Testing Summary, with
					 appropriate notations, shall be logged in the Office of the State Tuberculosis
					 Program on or before March 15th of each year for the twelve (12) months
					 preceding January 31st of that year.